Objective: Hemodialysis is a treatment modality for patients, in which physical and psychological stress factors are together. Intense anxiety and stress caused by treatment are very favorable for alexithymic feelings. Hemodialysis patients undergo continuous biochemical changes hemodynamically. Our aim in this study was to investigate the relationship between biochemical parameters; we use in hemodialysis patients’ follow-up and alexithymic emotions and stress factors. Methods: Fifty-one patients who received hemodialysis treatment due to end-stage renal failure in Bilecik Province in 2019 were included in the study. Routine biochemical follow-up data of patients, hemodialysis stressor scale, and Toronto alexithymia scale (TAS) were used in the study. The statistical significance level was determined as p
1. Kitamura T, Shima S, Sugawara M, Toda MA. Clinical and psychosocial correlatesof antenatal depression: a review. Psychother Psychosom 1996;65:117–23.
2. Ouimet MA, Primeau F, Cole MG. Psychosocial risk factors in poststrokedepression: a systematic review. Can J Psychiatry Rev Can Psychiatr 2001;46:819–28.
3. Kupfer DJ, Frank E. Role of psychosocial factors in the onset of major depression. The integrative neurobiology of affiliation. New York: New York Academy of Sciences; 1997. p. 429–39.
4. Sezer MT. Psychiatric Issues. Hemodialysis Physician Handbook. [Turkish]. Istanbul: Turkish Nephrology Society Publication; 1997:147–52. Available at: http://www.nefroloji.org.tr/folders/file/ psikiyatrik_sorunlar.pdf. Accessed Feb 17, 2021.
5. Kara B. Adherence to treatment in hemodialysis patients: a multipleaspectapproach. Gulhane Tip Derg 2017;49:132–6.
6. Ibrahim S, El Salamony O, Ibrahim S, El Salamony O. Depression, quality of lifeand malnutrition-inflammation scores in hemodialysis patients. Am J Nephrol 2008;28:784–91.
7. Sifneos PE. The prevalence of ‘alexithymic’ characteristicsin psychosomatic patients. Psychoter Psychosom 1973;22:255–262.
8. Taylor G, Bagby R, Parker J. The alexithymia construct. Apotential paradigm for psychosomatic medicine. Psychosomatics 1991;32:153– 164.
9. Saarijarvi S, Salminken JK, Tamminen T, Aarela E. Alexithymia in psychiatric consultation-liaison patients. Gen Hosp Psychiatry 1993;15:330–333.
10. Senturk A, Levent BA, Tamam L. The Psychopathology inPatients with Chronic Renal Failure Treated with Hemodialysis. Ondokuz Mayıs University Medical Journal 2000;17:163–72.
11. Pop-Jordanova N, Polenakovic M. Alexithymia Constructin Dialysis Patients. BANTAO Journal 2015;12:45–51.
12. Kiani GA, Kermanshahi S, Ahmadi F. Study of the effect of Benson’s relaxation technique on hemodynamic parameters and stress of discharge in acute myocardial infarction patients in Tehran, 2002. J Shaheed Sadoughi Univ Med Sci and Health Serv Yazd 2003;11:50–6.
13. Salbas E. The Twenty-Item Toronto Alexithymia Scale (TAS-20), 2016. Available at: http://www.ftronline.com/toronto-aleksitimi-olcegi/. Accessed May 20, 2017.
14. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216–26.
15. Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA 2010;303:1946–53.
16. Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis 2012;60:54–61.
17. Harwood L, Wilson B, Locking-Cusolito H, Sontrop J, Spittal J. Stressors and coping in individuals with chronic kidney disease. Nephrol Nurs J 2009;36:265–76, 301.
18. Griva K, Davenport A, Harrison M, Newman S. An evaluation of illness, treatment perceptions, and depression in hospital- vs. homebased dialysis modalities. J Psychosom Res 2010;69:363–70.
19. Spiegel BMR, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol 2008;3:1759–68.
20. Tanaka M, Yamazaki S, Yahashino Y, Fukuhara S, Akiba T, Saito A, et al. Hypercalcaemia is associated with poor mental health in haemodialysis patients: Results from Japan DOPPS. Nephrol Dial Transplant 2007;22:1658–64.
21. Lai C, Aceto P, Luciani M, Fazzari E, Cesari V, Luciano S, et al. Emotional management and biological markers of dietetic regimen in chronic kidney disease patients. RenFail 2017;39:173–8.
22. Allen KL, Miskulin D, Yan G, Dwyer JT, Frydrych A, Leung J, et al. Hemodialysis (HEMO) Study Group: Association of nutritional markers with physical and mental health status in prevalent hemodialysis patients from the HEMO study. J Ren Nutr 2002;12:160– 9.
23. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Physical symptoms and quality of life in patients on chronic dialysis: Results of the Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant 1999;14:1163–70.
24. Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT. NECOSAD study group: Validation of the KDQOL-SF: A dialysis-targeted health measure. Qual Life Res 2002;11:437–47.
25. Goller JL, McMahon JM, Rutledge C, Walker RG, Wood SE. Dialysis adequacy and self-reported health status in a group of CAPD patients. Adv Perit Dial 1997;13:128–33.
26. Kusek JW, Greene P, Wang SR, Beck G, West D, Jamerson K, et al. Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: The African American Study of Kidney Disease and Hypertension Trial. Am J Kidney Dis 2002;39:513–24.